MTD 1172.5 (+1.39%)
US5926881054Medical Diagnostics & ResearchDiagnostics & Research

Mettler-Toledo (MTD) Competitor Comparison

We are evaluating the key criteria listed to compare Mettler-Toledo (MTD) against its competitors in the Diagnostics & Research industry.

Performance 5 years - MTD ranking 11 / 58

These are the competitors of Mettler-Toledo in the industry Diagnostics & Research ranked by performance 5 years
1. Lantheus Holdings LNTH
682.42
2. Natera NTRA
464.47
3. RadNet RDNT
436.81
4. Medpace Holdings MEDP
362.55
5. Meridian Bioscience VIVO
118.46
6. Laboratory Corp of America Holdings LH
109.17
7. Quest Diagnostics DGX
101.17
8. Anixa Biosciences ANIX
98
9. Waters WAT
93.74
10. Thermo Fisher Scientific TMO
79.73
11. Mettler-Toledo MTD
77.24
12. IDEXX Laboratories IDXX
76.29
13. Danaher DHR
68.83
14. IQVIA Holdings IQV
65.85
15. Agilent Technologies A
64.21
16. DarioHealth DRIO
61.4
17. PerkinElmer PKI
48.44
18. Fulgent Genetics FLGT
43.28
19. Icon ICLR
33.3
20. Twist Bioscience TWST
30.4
21. Charles River Laboratories CRL
17.84
22. Ortho Clinical Diagnostics Holdings OCDX
13.74
23. Heska HSKA
12.14
24. Co-Diagnostics CODX
6.45
25. DexCom DXCM
2.13
26. Qiagen QGEN
-1.17
27. Syneos Health SYNH
-16.98
28. CareDx CDNA
-18.18
29. Exact Sciences EXAS
-24.46
30. Olink Holding OLK
-26.82
31. Guardant Health GH
-37.4
32. Myriad Genetics MYGN
-37.55
33. Inotiv NOTV
-38.75
34. Bioventus BVS
-40.2
35. Personalis PSNL
-50.75
36. Precipio PRPO
-56.09
37. Sotera Health SHC
-56.41
38. Psychemedics PMD
-59.3
39. NeoGenomics NEO
-62.58
40. Pacific Biosciences of California PACB
-62.99
41. Enzo Biochem ENZ
-65.26
42. Illumina ILMN
-69.17
43. National Research NRC
-69.62
44. Exagen XGN
-70.75
45. Neogen NEOG
-71.05
46. Sera Prognostics SERA
-76.42
47. Trinity Biotech TRIB
-81.02
48. MaxCyte MXCT
-83.93
49. Global Cord Blood CO
-86.47
50. Interpace Biosciences IDXG
-86.51
51. MDxHealth MDXH
-87.57
52. bioAffinity Technologies BIAF
-88.45
53. Neuronetics STIM
-92.42
54. Biodesix BDSX
-92.64
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-96.66

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.